logo

AMERISOURC(NYSE:ABC)
AmerisourceBergen Corporation is one of the world''s largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen''s service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education.
# Employees: 10900
Address: 1300 Morris Drive,Chesterbrook,PA,USA
Phone: 610 727-7000
Fax: 610-647-0141
Website: www.amerisourcebergen.com
Email: mkilpatric@amerisourcebergen.com
Sector: Retail/Wholesale
Industry: MED-WHSL DRG/SN
Executive Officers
Richard C Gozon (Chmn.; Dir.)
Jeanne B. Fisher (Sr. V.P.; Human Resources)
Michael D. Dicandilo (Exec. V.P.; C.F.O.; C.O.O.)
David R. Yost (Presi.; C.E.O.; Dir.)
John G. Chou (Sr. V.P.; Genl. Counsel.; Sec.,)
Dividend
Ex-Dividend Date: 11/19/2009
Annual Dividend: $0.32
Current Dividend Yield: $1.31
Dividend Paid (3 months): $0.08
Indicated Dividend: $0.14
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/21/2010
Mean EPS (Next Qtr): $0.42
Mean EPS (Year): $1.89
Mean Estimate(Long Term): $12.20
P/E Ratio(Based on EPS estimate): 12.980
Number of Estimates: 16
Shares Performance
Period ABC Compare to S&P
YTD 37.35 % 13.68 %
4 Weeks 5.61 % 4.47 %
12 Weeks 15.52 % 8.91 %
Shares Information
Analyst Coverage: Y
Avg Volume: 3226645
Shares Outstanding: 297M
Market Cap: $7.28B
52 Week High: $24.60
52 Week Low: $13.74
P/E Ratio: 14.410
PEG Ratio: 1.060
Split: On 6/16/2009 ABC split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 4.76 %
EPS Growth in Last Year: 20.55 %
Sales Growth in Last Quarter: 1.75 %
Sales Growth in Last Quarter: 9.08 %
Financials
Qtr Book Value: $2.68
Cash Flow/Share: $12.32
Change in Payout Ratio: 0.060
Price/Sales: 0.100
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia